STOP THE WAR! Let’s support Ukraine Together

Nocturne Acquisition Corp. (MBTC) to Combine with Cognos Therapeutics in $120M Deal

Nocturne Acquisition Corp. (MBTC) to Combine with Cognos Therapeutics in $120M Deal

Nocturne Acquisition Corp. (NASDAQ:MBTC) has entered into a definitive agreement to combine with medical technology company Cognos Therapeutics at an enterprise value of $120 million. Inglewood, California-based Cognos Therapeutics is a medical device company that develops diagnostic and drug delivery devices designed to detect diseases. The parties expect to close the deal in the second or third
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.